Pharmacokinetics and pharmacodynamics of the myotoxic venom of Pseudechis australis (mulga snake) in the anesthetised rat

References

• Johnston CI, Brown SG, O’Leary MA, Currie BJ, Greenberg R, Taylor M, et al. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19). Clin Toxicol (Phila) 2013; 51:417–424.
   PubMed Web of Science ®Google Scholar
• Gutierrez JM, Ponce-Soto LA, Marangoni S, Lomonte B. Systemic and local myotoxicity induced by snake venom group II phospholipases A2: comparison between crotoxin, crotoxin B and a Lys49 PLA2 homologue. Toxicon 2008; 51:80–92.
   PubMed Web of Science ®Google Scholar
• Churchman A, O’Leary M, Buckley N, Page C, Tankel A, Gavaghan C, et al. Clinical effects of red-bellied black snake (Pseudechis porphyriacus) envenoming and correlation with venom concentrations: Australian Snakebite Project (ASP-11). Med J Aust 2010; 193:696–700.
   PubMed Web of Science ®Google Scholar
• Pinho FM, Zanetta DM, Burdmann EA. Acute renal failure after Crotalus durissus snakebite: a prospective survey on 100 patients. Kidney Int 2005; 67:659–667.
   PubMed Web of Science ®Google Scholar
• Kularatne SA. Epidemiology and clinical picture of the Russell's viper (Daboia russelii russelii) bite in Anuradhapura, Sri Lanka: a prospective study of 336 patients. Southeast Asian J Trop Med Public Health 2003; 34:855–862.
   PubMedGoogle Scholar
• Wickramaratna JC, Fry BG, Aguilar MI, Kini RM, Hodgson WC. Isolation and pharmacological characterization of a phospholipase A2 myotoxin from the venom of the Irian Jayan death adder (Acanthophis rugosus). Br J Pharmacol 2003; 138:333–342.
   PubMed Web of Science ®Google Scholar
• Lomonte B, Angulo Y, Calderon L. An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon 2003; 42:885–901.
   PubMed Web of Science ®Google Scholar
• Fuly A, Calil-Elias S, Zingali R, Guimaraes J, Melo PA. Myotoxic activity of an acidic phospholipase A2 isolated from Lachesis muta (Bushmaster) snake venom. Toxicon 2000; 38:961–972.
   PubMed Web of Science ®Google Scholar
• Dixon RW, Harris JB. Myotoxic activity of the toxic phospholipase, notexin, from the venom of the Australian tiger snake. J Neuropathol Exp Neurol 1996; 55:1230–1237.
   PubMed Web of Science ®Google Scholar
• Fatehi M, Rowan EG, Harvey AL, Harris JB. The effects of five phospholipases A2 from the venom of king brown snake, Pseudechis australis, on nerve and muscle. Toxicon 1994; 32: 1633–1643.
   Google Scholar
• Gutierrez JM, Ownby CL. Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity. Toxicon 2003; 42:915–931.
   PubMed Web of Science ®Google Scholar
• Ponraj D, Gopalakrishnakone P. Establishment of an animal model for myoglobinuria by use of a myotoxin from Pseudechis australis (king brown snake) venom in mice. Lab Anim Sci 1996; 46:393–398.
   PubMedGoogle Scholar
• Ponraj D, Gopalakrishnakone P. Morphological changes induced by a generalized myotoxin (myoglobinuria-inducing toxin) from the venom of Pseudechis australis (king brown snake) in skeletal muscle and kidney of mice. Toxicon 1995; 33:1453–1467.
   PubMed Web of Science ®Google Scholar
• Moreno E, Gutierrez JM. Body distribution of Bothrops asper (terciopelo) snake venom myotoxin and its relationship to pathological changes. Toxicon 1988; 26:403–409.
   PubMed Web of Science ®Google Scholar
• Gutierrez JM, Ownby CL, Odell GV. Skeletal muscle regeneration after myonecrosis induced by crude venom and a myotoxin from the snake Bothrops asper (Fer-de-Lance). Toxicon 1984; 22:719–731.
   PubMed Web of Science ®Google Scholar
• Ownby CL, Colberg TR, Claypool PL, Odell GV. In vivo test of the ability of antiserum to myotoxin a from prairie rattlesnake (Crotalus viridis viridis) venom to neutralize local myonecrosis induced by myotoxin a and homologous crude venom. Toxicon 1984; 22:99–105.
   PubMed Web of Science ®Google Scholar
• Ponraj D, Gopalakrishnakone P. Renal lesions in rhabdomyolysis caused by Pseudechis australis snake myotoxin. Kidney Int 1997; 51:1956–1969.
   PubMed Web of Science ®Google Scholar
• Ireland G, Brown SG, Buckley NA, Stormer J, Currie BJ, White J, et al. Changes in serial laboratory test results in snakebite patients: when can we safely exclude envenoming? Med J Aust 2010; 193:285–290.
   PubMed Web of Science ®Google Scholar
• Rowlands JB, Mastaglia FL, Kakulas BA, Hainsworth D. Clinical and pathological aspects of a fatal case of mulga (Pseudechis australis) snakebite. Med J Aust 1969; 1:226–230.
   PubMed Web of Science ®Google Scholar
• Chen SZ, Gopalakrishnakone P, Gwee MC. Pharmacological effects and pathological changes induced by the venom of Pseudechis australis in isolated skeletal muscle preparations. Toxicon 1994; 32:303–315.
   PubMed Web of Science ®Google Scholar
• White J. CSL Antivenom Handbook. Melbourne: CSL Ltd; 2001.
   Google Scholar
• Ramasamy S, Isbister GK, Hodgson WC. The efficacy of two antivenoms against the in vitro myotoxic effects of black snake (Pseudechis) venoms in the chick biventer cervicis nerve-muscle preparation. Toxicon 2004; 44:837–845.
   PubMed Web of Science ®Google Scholar
• Gutierrez JM, Leon G, Rojas G, Lomonte B, Rucavado A, Chaves F. Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom. Toxicon 1998; 36:1529–1538.
   PubMed Web of Science ®Google Scholar
• Rocha ML, Valença RC, Maia MBS, Guarnieri MC, Araujo IC, Araujo DAM. Pharmacokinetics of the venom of Bothrops erythromelas labeled with 131I in mice. Toxicon 2008; 52:526–529.
   PubMed Web of Science ®Google Scholar
• Riviere G, Choumet V, Audebert F, Sabouraud A, Debray M, Scherrmann JM, Bon C. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy. J Pharmacol Exp Ther 1997; 281:1–8.
   PubMed Web of Science ®Google Scholar
• Maung-Maung T, Khin-Mee M, Mi-Mi K, Thein T. Kinetics of envenomation with Russell's viper (Vipera russelli) venom and of antivenom use in mice. Toxicon 1988; 26:373–378.
   PubMed Web of Science ®Google Scholar
• Isbister GK, O’Leary MA, Schneider JJ, Brown SG, Currie BJ, ASP Investigators. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies. Toxicon 2007; 49:57–67.
   PubMed Web of Science ®Google Scholar
• Kulawickrama S, O’Leary MA, Hodgson WC, Brown SG, Jacoby T, Davern K, Isbister GK. Development of a sensitive enzyme immunoassay for measuring taipan venom in serum. Toxicon 2010; 55:1510–1518.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Hooper MR, Dowsett R, Maw G, Murray L, White J. Collett's snake (Pseudechis colletti) envenoming in snake handlers. QJM 2006; 99:109–115.
   PubMed Web of Science ®Google Scholar
• Saul ME, Thomas PA, Dosen PJ, Isbister GK, O’Leary MA, Whyte IM, et al. A pharmacological approach to first aid treatment for snakebite. Nat Med 2011; 17:809–811.
   PubMed Web of Science ®Google Scholar
• Mello SM, Linardi A, Renno AL, Tarsitano CA, Pereira EM, Hyslop S. Renal kinetics of Bothrops alternatus (Urutu) snake venom in rats. Toxicon 2010; 55:470–480.
   PubMed Web of Science ®Google Scholar
• Ismail M, Aly MH, Abd-Elsalam MA, Morad AM. A three- compartment open pharmacokinetic model can explain variable toxicities of cobra venoms and their alpha toxins. Toxicon 1996; 34:1011–1026.
   PubMed Web of Science ®Google Scholar
• Rangel-Santos A, Dos-Santos EC, Lopes-Ferreira M, Lima C, Cardoso DF, Mota I. A comparative study of biological activities of crotoxin and CB fraction of venoms from Crotalus durissus terrificus, Crotalus durissus cascavella and Crotalus durissus collilineatus. Toxicon 2004; 43:801–810.
   PubMed Web of Science ®Google Scholar